Who owns Ovid Therapeutics?
- Ticker: OVID
- CUSIP Number: 690469101
Tip: Access positions for across all investors
Analyze quarterly positions in Ovid Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ovid Therapeutics stock
Who bought or sold Ovid Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 6.9M | $22M | 0% | Dec 2023 |
|
| EcoR1 Capital | 6.1M | $20M | 0% | Dec 2023 |
|
| Madison Avenue Partners | 3.6M | $12M | 0% | Dec 2023 |
|
| Vanguard Group | 3.0M | $9.6M | 1% | Dec 2023 |
|
| Artal Group | 2.5M | $8.1M | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 1.6M | $5.3M | 1% | Dec 2023 |
|
| TLS Advisors | 1.3M | $4.2M | 0% | Dec 2023 |
|
| Blue Owl Capital Holdings | 865k | $2.8M | 100% | Dec 2023 |
|
| Wells Fargo & Company | 449k | $1.4M | 1% | Dec 2023 |
|
| Fft Wealth Management | 396k | $1.3M | 100% | Dec 2023 |
|
| Bank of New York Mellon | 249k | $801k | -1% | Dec 2023 |
|
| Dimensional Fund Advisors | 243k | $783k | 70% | Dec 2023 |
|
| Charles Schwab Investment Management | 162k | $521k | -5% | Dec 2023 |
|
| Barclays | 82k | $264k | 661% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 81k | $261k | 0% | Dec 2023 |
|
| Rhumbline Advisers | 80k | $257k | -4% | Dec 2023 |
|
| Assenagon Asset Management | 79k | $253k | 100% | Dec 2023 |
|
| D. E. Shaw & Co | 78k | $252k | -7% | Dec 2023 |
|
| Tejara Capital | 73k | $236k | 100% | Dec 2023 |
|
| UBS Group | 72k | $232k | 50% | Dec 2023 |
|
| Jacobs Levy Equity Management | 62k | $201k | 0% | Dec 2023 |
|
| Goldman Sachs Group | 62k | $199k | 9% | Dec 2023 |
|
| Bank of America Corporation | 54k | $175k | 37% | Dec 2023 |
|
| Jane Street | 51k | $164k | 100% | Dec 2023 |
|
| Bank of Nova Scotia | 44k | $142k | 0% | Dec 2023 |
|
| SG Americas Securities | 40k | $128k | 53% | Dec 2023 |
|
| Mirae Asset Global Investments | 34k | $110k | 5% | Dec 2023 |
|
| MetLife Investment Advisors | 32k | $102k | 0% | Dec 2023 |
|
| American International | 30k | $95k | 0% | Dec 2023 |
|
| Virtu Financial | 24k | $78k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 23k | $75k | 82% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 23k | $74k | -5% | Dec 2023 |
|
| William Blair $ Company | 22k | $70k | -2% | Dec 2023 |
|
| New York State Common Retirement Fund | 19k | $61k | -1% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 18k | $59k | 113% | Dec 2023 |
|
| Florida State Board of Administration | 17k | $56k | 0% | Dec 2023 |
|
| Newman Dignan & Sheerar | 17k | $53k | 100% | Dec 2023 |
|
| T. Rowe Price Associates | 14k | $46k | 6% | Dec 2023 |
|
| Citadel Advisors | 13k | $43k | 100% | Dec 2023 |
|
| ADAR1 Capital Management | 13k | $43k | 100% | Dec 2023 |
|
| Bailard | 13k | $41k | 0% | Dec 2023 |
|
| Squarepoint Ops | 11k | $37k | 100% | Dec 2023 |
|
| Citigroup | 10k | $32k | 34472% | Dec 2023 |
|
| China Universal Asset Management | 8.2k | $26k | 100% | Dec 2023 |
|
| Amalgamated Bank | 5.2k | $17k | -10% | Dec 2023 |
|
| Legal & General Group | 5.2k | $17k | 13% | Dec 2023 |
|
| Summit Investment Advisors | 4.9k | $16k | 0% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 3.3k | $11k | 0% | Dec 2023 |
|
| Sandy Spring Bank | 2.0k | $6.4k | 0% | Dec 2023 |
|
| Advisor Group Holdings | 306.00 | $985.014000 | 0% | Dec 2023 |
|
| ICA Group Wealth Management | 55.00 | $177.001000 | 100% | Dec 2023 |
|
| Pnc Financial Services | 10.00 | $32.000000 | 100% | Dec 2023 |
|
| Sound Income Strategies | 6.00 | $18.000000 | 100% | Mar 2024 |
|
| CWM | 5.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Ovid Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jump Financial | Sep 2023 | 16k | $61k |
| Cutler | Dec 2023 | 2.1k | $6.0k |
| Russell Investments | Sep 2023 | 57.00 | $218.999700 |